<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1251</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-5-74-77</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Investment activity of pharmaceutical enterprises: 9 months of 2017</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Svetlana</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2018-12-05" publication-format="electronic"><day>05</day><month>12</month><year>2018</year></pub-date><issue>5</issue><fpage>74</fpage><lpage>77</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>The investment efficiency of the subsector enterprises was analysed using the data of the state statistical reporting form No. P-2 «Information on investments to non-financial assets» (quarterly).</abstract><kwd-group xml:lang="en"><kwd>medical industry</kwd><kwd>pharmaceutical industry</kwd><kwd>drugs</kwd><kwd>enterprises</kwd><kwd>analysis</kwd><kwd>investments</kwd><kwd>fixed capital</kwd><kwd>own funds</kwd><kwd>raised funds</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>медицинская промышленность</kwd><kwd>фармацевтическая промышленность</kwd><kwd>лекарственные средства</kwd><kwd>предприятия</kwd><kwd>анализ</kwd><kwd>инвестиции</kwd><kwd>основной капитал</kwd><kwd>собственные средства</kwd><kwd>привлеченные средства</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Романова С.А. Инвестиционная активность предприятий фармотрасли: 9 месяцев 2016 год. Ремедиум, 2017, 5: 50-52.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Захарова В.М., Романова С.А. Инвестиции в развитие медицинской промышленности. Лучше мало, чем ничего. Ремедиум, 2000, 10: 20-27.</mixed-citation></ref></ref-list></back></article>
